MB and polymyositis: When FDG shows marked diffuse accumulation in the skeletal muscles, such as polymyositis [79] and the patient experiences muscle weakness and pain with increased serum creatine phosphokinase or myoglobin levels, the drugs that may cause rhabdomyolysis should be identified and stopped immediately to prevent serious renal failure.